Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard L Parnes

Showing results (81-90 of 110) with videos related to

Pageof 11
Sort By:
The Journal of Urology|October 19, 2010
Androgen receptor CAG repeat length and association with prostate cancer risk: results from the prostate cancer prevention trialDouglas K Price, Cindy H Chau, Cathee Till, et al.
Plos One|May 9, 2015
Finasteride concentrations and prostate cancer risk: results from the Prostate Cancer Prevention TrialCindy H Chau, Douglas K Price, Cathee Till, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 23, 2016
Prospective Study Evaluating Na18F PET/CT in Predicting Clinical Outcomes and Survival in Advanced Prostate CancerAndrea B Apolo, Liza Lindenberg, Joanna H Shih, et al.
The Journal of Urology|December 28, 2020
Magnetic Resonance Imaging-Targeted and Systematic Biopsy for Detection of Grade Progression in Patients on Active Surveillance for Prostate CancerNitin K Yerram, Lori Long, Luke P O'Connor, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 16, 2015
Randomized, Placebo-Controlled Trial of Green Tea Catechins for Prostate Cancer PreventionNagi B Kumar, Julio Pow-Sang, Kathleen M Egan, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 27, 2024
Phase II Clinical Chemoprevention Trial of Weekly Erlotinib before Bladder Cancer SurgeryTracy M Downs, Howard H Bailey, Taja Lozar, et al.
Oncoimmunology|September 14, 2016
TARP vaccination is associated with slowing in PSA velocity and decreasing tumor growth rates in patients with Stage D0 prostate cancerLauren V Wood, Antonio Fojo, Brenda D Roberson, et al.
The Prostate|March 21, 2017
Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the Prostate Cancer Prevention TrialDanyelle A Winchester, Cathee Till, Phyllis J Goodman, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 8, 2011
Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917James R Marshall, Catherine M Tangen, Wael A Sakr, et al.
The Prostate|January 16, 2016
Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the prostate cancer prevention trialDanyelle A Winchester, Bora Gurel, Cathee Till, et al.
Pageof 11

Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
The Journal of Urology|October 19, 2010
Androgen receptor CAG repeat length and association with prostate cancer risk: results from the prostate cancer prevention trialDouglas K Price, Cindy H Chau, Cathee Till, et al.
Plos One|May 9, 2015
Finasteride concentrations and prostate cancer risk: results from the Prostate Cancer Prevention TrialCindy H Chau, Douglas K Price, Cathee Till, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 23, 2016
Prospective Study Evaluating Na18F PET/CT in Predicting Clinical Outcomes and Survival in Advanced Prostate CancerAndrea B Apolo, Liza Lindenberg, Joanna H Shih, et al.
The Journal of Urology|December 28, 2020
Magnetic Resonance Imaging-Targeted and Systematic Biopsy for Detection of Grade Progression in Patients on Active Surveillance for Prostate CancerNitin K Yerram, Lori Long, Luke P O'Connor, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 16, 2015
Randomized, Placebo-Controlled Trial of Green Tea Catechins for Prostate Cancer PreventionNagi B Kumar, Julio Pow-Sang, Kathleen M Egan, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 27, 2024
Phase II Clinical Chemoprevention Trial of Weekly Erlotinib before Bladder Cancer SurgeryTracy M Downs, Howard H Bailey, Taja Lozar, et al.
Oncoimmunology|September 14, 2016
TARP vaccination is associated with slowing in PSA velocity and decreasing tumor growth rates in patients with Stage D0 prostate cancerLauren V Wood, Antonio Fojo, Brenda D Roberson, et al.
The Prostate|March 21, 2017
Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the Prostate Cancer Prevention TrialDanyelle A Winchester, Cathee Till, Phyllis J Goodman, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 8, 2011
Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917James R Marshall, Catherine M Tangen, Wael A Sakr, et al.
The Prostate|January 16, 2016
Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the prostate cancer prevention trialDanyelle A Winchester, Bora Gurel, Cathee Till, et al.
Pageof 11